cMet is an HGF receptor; HGF–cMet axis activation is implicated in cellular invasion and metastasis through promotion of proliferation, migration, mobility, three-dimensional epithelial cell organization, and angiogenesis in HCC [25,31]. Here, MET is linked to hepatocellular carcinoma.